US Patent Issued to The General Hospital, President and Fellows of Harvard College on July 8 for "Engineered human-endogenous virus-like particles and methods of use thereof for delivery to cells" (Massachusetts Inventors)

ALEXANDRIA, Va., July 9 -- United States Patent no. 12,351,814, issued on July 8, was assigned to The General Hospital Corp. (Boston) and President and Fellows of Harvard College (Cambridge, Mass.).

"Engineered human-endogenous virus-like particles and methods of use thereof for delivery to cells" was invented by J. Keith Joung (Winchester, Mass.) and Peter Cabeceiras (Boston).

According to the abstract* released by the U.S. Patent & Trademark Office: "Human-derived virus-like particles (heVLPs), comprising a membrane comprising a phospholipid bilayer with one or more HERV-derived envelope proteins on the external side; one or more HERV-derived GAG proteins in the heVLP core, and a cargo molecule, e.g., a biomolecule and/or chemical cargo...